ArticleEMBO reports2023
Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury.
Si-Yuan Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleEMBO reports2023
Si-Yuan Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.